These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25561419)
1. Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications. Flory JH; Hennessy S JAMA Intern Med; 2015 Mar; 175(3):458-9. PubMed ID: 25561419 [No Abstract] [Full Text] [Related]
2. The FDA Revises Restrictions on Metformin Use in Kidney Impairment. Aschenbrenner DS Am J Nurs; 2016 Aug; 116(8):22-3. PubMed ID: 27466921 [No Abstract] [Full Text] [Related]
3. [Metformin should not be used by patients with reduced renal function]. Gudmundsdottir H; Brørs O; Os I Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417 [No Abstract] [Full Text] [Related]
4. Use of computer alerts to prevent the inappropriate use of metformin in an inpatient setting. Rossi AP; Wellins CA; Savic M; Devlin JT Qual Manag Health Care; 2012; 21(4):235-9. PubMed ID: 23011070 [TBL] [Abstract][Full Text] [Related]
5. Clinical development of metformin extended-release tablets for type 2 diabetes: an overview. Schwartz SL; Gordi T; Hou E; Cramer M; Heritier M; Cowles VE Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1235-43. PubMed ID: 18721117 [TBL] [Abstract][Full Text] [Related]
10. Lactic acidosis due to metformin. Prescrire Int; 1999 Jun; 8(41):85. PubMed ID: 10558450 [TBL] [Abstract][Full Text] [Related]
11. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients. del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422 [TBL] [Abstract][Full Text] [Related]
12. [Lactic acidosis feared adverse effect of metformin treatment. New guidelines can increase vigilance]. Berne C; Hietala SO Lakartidningen; 1999 Dec; 96(50):5598-9. PubMed ID: 10643216 [No Abstract] [Full Text] [Related]
13. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G; J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588 [TBL] [Abstract][Full Text] [Related]
14. Unexpected survival from severe metformin-associated lactic acidosis. Schure PJ; de Gooijer A; van Zanten AR Neth J Med; 2003 Oct; 61(10):331-3. PubMed ID: 14708912 [TBL] [Abstract][Full Text] [Related]
15. Do risk factors for lactic acidosis influence dosing of metformin? Millican S; Cottrell N; Green B J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389 [TBL] [Abstract][Full Text] [Related]
16. Establishing pragmatic estimated glomerular filtration rate thresholds to guide metformin prescribing: careful assessment of risks and benefits is required. George JT; McKay GA Diabet Med; 2008 May; 25(5):636-7. PubMed ID: 18346163 [No Abstract] [Full Text] [Related]
17. Contraindications to use of metformin. Age and creatinine clearance need to be taken into consideration. Elder AT BMJ; 2003 Apr; 326(7392):762; author reply 762. PubMed ID: 12676851 [No Abstract] [Full Text] [Related]